Medical and Quality-of-Life Updates from the 44th Annual ASCO Meeting
Speaker: Clifford A. Hudis, MD
Learn about the latest findings from the annual meeting of the American Society of Clinical Oncology. Dr. Hudis discusses results of chemotherapy development trials, information about zoledronic acid (brand name: Zometa) in the adjuvant setting, news on bevacizumab (brand name: Avastin), developments in HER2 positive breast cancer and information on triple-negative breast cancer research and treatment.
Download the Transcript:
LBBC Medical and Quality of Life Updates from 44th Annual ASCO Mtg.pdf 189.39 kB PDF File